Orexin B 5 mg
A neuropeptide (hypocretin-2) derived from a common precursor with orexin A.
CAD $116.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0113 Listed amount per vial: 5 mg Sales unit: 1 vial
Read the research in context.
A neuropeptide (hypocretin-2) derived from a common precursor with orexin A.
- Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior — source
- orexin-B: Ligand page, IUPHAR/BPS Guide to PHARMACOLOGY — source
- Orexin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: Provide supplier specification/SDS with exact identity (structure or sequence, stereochemistry/modifications and salt), active amount basis, excipients, physical form, packaging/fill, and lot-linked analytical evidence. No batch facts are verified by the catalogue alone. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for Orexin B, product reference MRD-0113.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 5 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.